Monogenic diabetes is often misdiagnosed with type 2 diabetes due to overlapping characteristics. This study aimed to discover novel causative mutations of monogenic diabetes in patients with clinically diagnosed type 2 diabetes and to explore potential molecular mechanisms. Whole-exome sequencing was performed on 31 individuals clinically diagnosed with type 2 diabetes. One novel heterozygous mutation (p.Ala2Thr) in INS was identified. It was further genotyped in an additional case-control population (6523 cases and 4635 controls), and this variant was observed in 0.09% of cases. Intracellular trafficking of insulin proteins was assessed in INS1-E and HEK293T cells. p.Ala2Thr preproinsulin-GFP was markedly retained in the endoplasmic reticulum (ER) in INS1-E cells. Activation of the PERK-eIF2α-ATF4, IRE1α-XBP1, and ATF6 pathways as well as upregulated ER chaperones were detected in INS1-E cells transfected with the p.Ala2Thr mutant. In conclusion, we identified a causative mutation in INS responsible for maturity-onset diabetes of the young 10 (MODY10) in a Chinese population and demonstrated that this mutation affected β cell function by inducing ER stress.
Introduction
The estimated prevalence of diabetes mellitus in Chinese adults was as high as 11.6% in 2010, making it one of the leading causes of mortality in China (Xu et al., 2013) . In particular, >90% of diabetes patients were clinically diagnosed with type 2 diabetes mellitus (T2DM). However, as molecular diagnosis technology developed, some T2DM patients are genetically diagnosed with monogenic diabetes. A study conducted in the US showed that 51% of children and adolescents with the most common form of monogenic diabetes (maturity-onset diabetes of the young, MODY) were misdiagnosed with T2DM (Pihoker et al., 2013) . In Chinese populations, only mutations for the MODY5 gene HNF-1β and the MODY6 gene Neuro D1 were identified in early-onset T2DM families through direct sequencing (Wang et al., 2004; Liu et al., 2007) .
With the development of genome-wide association studies (GWASs), >90 T2DM loci have been discovered that can identify genetically high risk populations (Sun et al., 2014; Bonnefond and Froguel, 2015; Mohlke and Boehnke, 2015) . Several prospective studies in people with European ancestry have demonstrated that combining multiple loci as a genetic risk score (GRS) could predict the incidence of T2DM (Meigs et al., 2008; Cornelis et al., 2009) . We previously found that individuals from a Chinese population with a higher GRS were susceptible to T2DM and impaired glucose regulation (IGR) during a 9-year follow-up study (Yan et al., 2016) . However, some individuals with fewer risk alleles and a low environmental risk, who were defined as the 'low risk' population of T2DM, also developed diabetes at an earlier age. Thus, unknown monogenic causes may contribute in a meaningful proportion to the genetic architecture of T2DM. It is necessary to identify novel monogenic aetiologies in Chinese T2DM patients.
In this study, we used whole-exome sequencing (WES), which captures both common and rare genetic variations in the protein-coding regions of genes, in clinically diagnosed T2DM patients with low genetic and environmental risk to discover potential monogenic mutations. We further carried out functional studies to explore potential mechanisms by which the identified mutations lead to the development of diabetes, such as impairing pancreatic β cell development, disrupting insulin synthesis or secretion, and inducing endoplasmic reticulum (ER) stress.
Results

Identification of the INS mutation and its clinical presentation in diabetes
The mean depth of our WES was 65× in the targeted regions. After quality control processing of the sequence data (variants with a coverage of <20 were discarded), 646181 genetic variants were observed in the 31 samples, among which 67468 were novel variations not included in the HapMap, dbSNP, or 1000 Genome Project data sets. In the protein-coding regions of genes, 27 variants (0.01%) were splice variants, 1655 (0.62%) were nonsense variants, 127862 (47.9%) were missense variants, and 137153 (51.4%) were synonymous variants.
Of these variants, a new mutation in INS was identified in one male patient. The missense mutation GCC > ACC (c. G4A) is located in the signal peptide, leading to the amino acid replacement p.Ala2Thr (A2T). The patient was diagnosed with T2DM at 31 years with a high fasting plasma glucose level (16 mmol/L) and treated with oral hypoglycaemic agents (OHAs; gliclazide and acarbose). No autoimmunity against the pancreas was detected, as the patient was negative for autoantibodies. To determine the prevalence of the A2T mutation in the Chinese population, we subsequently genotyped this mutation in 11158 individuals, including 6523 cases (5515 with T2DM and 1008 with IGT) and 4635 controls. The A2T mutation was detected in 0.09% of patients (n = 6) and 0% of controls (P = 0.0451 by Fisher's exact test). The clinical characteristics of the other five A2T mutation carriers are shown in Supplementary Table S1 .
Impact of the INS mutation on intracellular trafficking ex vivo
To investigate the pathogenesis of the A2T mutation, functional studies were carried out. The pcDNA3.1-WT-EGFP and pcDNA3.1-A2T-EGFP plasmids were constructed and separately transfected into HEK293T cells. The mRNA expression level of mutant INS was similar to that of wild-type INS ( Figure 1A) . Insulin is synthesized as a single precursor protein containing the signal peptide in the cytoplasm. The precursor is then cleaved of the signal peptide to produce proinsulin that enters into the cisternal space of the rough ER. The protein level of mixed proinsulin and uncleaved or improperly cleaved preproinsulin in total cell extracts of A2T-transfected INS1-E and HEK293T cells was higher than that of WT-transfected cells ( Figure 1B (1 μg/well) separated on 12% reducing SDS-PAGE and probed first with an anti-GFP antibody, followed by tubulin as a loading control. The protein levels were quantified by densitometry from the immunoblots. (C) Western blot of total protein (20 μg/lane) from HEK293T cells transfected with INS constructs (2 μg/well) or the pEGFP-N1 vector (1 μg/well). Data in B and C are presented as mean ± SEM (n = 3). *P < 0.05 and **P < 0.01 vs. WT. ND, no significant difference.
Subcellular localization of mutant insulin-GFP
Wild-type and mutant insulin proteins were expressed in INS1-E cells, and the subcellular localization was examined after 48 h by confocal microscopy, where green fluorescence indicated the recombinant insulin and red fluorescence represented the ER. As shown in Figure 2A , wild-type insulin-GFP was stored compactly, properly targeted to secretory granules, and showed little colocalization with the ER. In contrast, the A2T insulin-GFP displayed diffused distribution in less compacted granules and close colocalization with the ER (Figure 2A ). In addition, the integrated optical density (IOD) of merged areas, calculated using ImagePro Plus software showed a significant difference of colocalization between WT and A2T groups (P < 0.001 by t-test), indicating an increased A2T insulin-GFP retention in the ER ( Figure 2B ).
Impact of the INS mutation on ER stress
Unfolded and misfolded proteins accumulate in the ER to trigger an adaptive cellular response termed the unfolded protein response (UPR) that initially upregulates ER chaperones and activates three canonical signaling branches of the UPR to relieve ER stress; however, in the longer term, the UPR induces cell death (Ozcan and Tabas, 2012; Dufey et al., 2014; Lee and Ozcan, 2014) .
ER retention of the A2T mutant prompted us to examine whether this mutant triggered the UPR in INS1-E cells. As a result, A2T mutant transfection in INS1-E cells showed similar effects as the chemical ER stressor thapsigargin (Tg) (Treiman et al., 1998) on activation of the UPR and induction of ER stress (Figures 3 and 4) . Both phosphorylation of inositol-requiring enzyme 1 (IRE1) and eukaryotic initiation factor 2α (eIF2α) ( Figure 3 ) and mRNA abundance of activating transcription factor 4 (ATF4), spliced XBP1, ATF6, and the ER chaperones BiP, GRP94, calreticulin, and calnexin ( Figure 4) were markedly increased. In contrast, WT transfection only induced basal levels of stress, similar to the control vector PC but higher than the negative control (NC, untransfected cells) (Figures 3 and 4) .
We next explored whether the A2T mutant affected ER stressinduced apoptosis. mRNA expression of BAX, BID, BCL-2, FADD, and CHOP and protein levels of cleaved caspase-3 and cleaved PARP as cell apoptosis markers were examined. We did not detect any differences between the wild-type and A2T mutation groups in these apoptosis markers (Figures 5 and 6) , indicating that the A2T mutation might only induce ER stress, but was not sufficient to cause apoptosis cascade. INS1-E cells were transfected with wild-type or mutant constructs, allowing 48 h for protein expression or treated with 1 μmol/L thapsigargin (Tg) for 3 h, and total protein was extracted. Immunoblot analysis of p-IRE1α, p-eIF2α, IRE1α, eIF2α, and BiP protein expression. Tubulin was used as the loading control. The ratios of p-IRE1α/IRE1α and p-eIF2α/eIF2α were quantified (n = 3 independent experiments). NC, negative control (untransfected cells). Data were normalized to the values of the wild-type group and are presented as mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. WT by t-test. Figure 4 mRNA expression of ER stress markers induced by the INS mutant. INS1-E cells were transfected with the wild-type or mutant construct or the pcDNA3.1(-) vector, allowing 24 h for mRNA expression or treated with 1 μmol/L thapsigargin (Tg) for 3 h, and total RNA was extracted. Real-time quantification of ATF4, spliced XBP1, ATF6, BiP, GRP94, calreticulin (CRT), and calnexin (CNX) mRNA expression, normalized to endogenous β-actin (n = 3 independent experiments). NC, negative control (untransfected cells). Data were normalized to the values of the wild-type group and are presented as mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. WT by t-test.
Figure 5 mRNA expression of apoptosis markers induced by the INS mutant. INS1-E cells were transfected with the wild-type or mutant construct, allowing 24 h for mRNA expression or treated with 1 μmol/L thapsigargin (Tg) for 8 h, and total RNA was extracted. Real-time quantification of BAX, BID, BCL-2, FADD, and CHOP mRNA expression, normalized to endogenous β-actin (n = 3 independent experiments). NC, negative control (untransfected cells). Data were normalized to the values of the wild-type group and are presented as mean ± SEM. *P < 0.05 and **P < 0.01 vs. WT by t-test.
Discussion
T2DM is a common complex metabolic disorder that has a strong genetic predisposition component. Currently, progress in GWASs has enabled the identification of >90 genetic loci for T2DM. However, the known variants explain only a small portion of T2DM heritability (McCarthy, 2010) , indicating that monogenic aetiologies may be involved. In the present study, we performed comprehensive, high-coverage WES for 31 'T2DM' patients and a subsequent replication study of a cross-sectional population consisting of 6523 cases and 4635 controls. A novel A2T mutation in the INS gene was discovered contributing to the development of monogenic diabetes.
Single mutations in the human INS gene leading to pancreatic β cell dysfunction and diabetes have been reported since 2007. Most INS mutations lead to permanent neonatal diabetes mellitus (PNDM) (Støy et al., 2007; Colombo et al., 2008; Bonfanti et al., 2009; Huang et al., 2014) , while INS has also recently been identified as being responsible for MODY10 (Edghill et al., 2008; Molven et al., 2008; Boesgaard et al., 2010; Meur et al., 2010; Dusatkova et al., 2015; Piccini et al., 2016) . Several European pedigrees of MODY have been identified carrying the INS mutations p.Arg6Cys, p.Arg6His, p.Leu30Met, p.Val42Ala, p.Arg46Gln, p.Arg55Cys, and the frameshift mutation p.Gln78fs, which can be connected with a wide spectrum of phenotypes even within one family. However, no INS mutations responsible for MODY have been reported in the Chinese population. Thus, our study for the first time demonstrated that p.Ala2Thr is causative of MODY10 in a Chinese population. Since the prevalence of p.Ala2Thr in INS is 0.09% in patients and 0% in controls in the present study, we consider it a MODY10 hot spot mutation in the Chinese population. Due to the absence of familial genotype information, we could not confirm p.Ala2Thr as a de novo mutation in the pedigrees. However, this mutation has never been reported in the literature, and thus we are prone to consider it as a novel mutation of diabetes in the Chinese.
In addition, we carried out functional studies with the A2T substitution. The INS gene encodes a single chain precursor preproinsulin in the cytoplasm with a signal peptide. Preproinsulin is targeted to and translocated across the ER membrane and proteolytically processed by signal peptidase, forming proinsulin. Subsequently, proinsulin is folded and delivered to the Golgi apparatus to form mature insulin that is stored in secretory granules (Dodson and Steiner, 1998; Kim et al., 2012) . Here, the substitution of a hydrophobic amino acid (alanine) with a hydrophilic one (threonine) in the signal peptide altered the affinity for water and structural stability of preproinsulin, suggesting that not only A2T leads to inefficient signal peptide cleavage but also the cleavage occurs at an alternative site, producing an abnormal proinsulin. When the A2T mutant protein was transiently expressed in cells, the combination of uncleaved and improperly cleaved preproinsulin caused retention in the ER but did not undergo the normal folding pathway of proinsulin.
Continuous expression of unfolded or misfolded proteins in the ER induces ER stress, activating the adaptive cellular UPR. Upon ER stress, the ER chaperone BiP preferentially relocates its binding to unfolded proteins concomitant with the activation of the three UPR signaling pathways, IRE1α-XBP1, PERK-eIF2α-ATF4-Chop, and ATF6. In addition, N-terminal ATF6 translocates to the nucleus and upregulates the transcription of a network of chaperones that assist in protein folding. There is powerful evidence implicating prolonged ER stress in the development and progression of type 2 diabetes (Back and Kaufman, 2012; Hasnain et al., 2016; Meyerovich et al., 2016) . In our study, the accumulation of A2T proinsulin molecules triggered significant ER stress in vitro. Increased phosphorylation of IRE1α and eIF2α, elevated mRNA expression of XBP1s, ATF4, and ATF6, and upregulated expression of the ER chaperones BiP, GRP94, calreticulin, and calnexin were all detected in INS1-E cells, which could increase the ER folding capacity and decrease the burden of misfolded proteins. However, the mutation exhibited a limited impact on β cell survival, as it did not trigger apoptosis in our study.
In conclusion, we discovered a novel mutation, p.Ala2Thr, in INS causative of MODY10 in a Chinese population through WES. In vitro studies demonstrated that this mutation impaired β cell function by inducing ER retention and thus triggering ER stress.
Materials and methods
Sample selection for WES and replication
In total, 31 patients were selected for WES from 3410 patients with T2DM previously genotyped in Shanghai Diabetes Institute Inpatients Database (Jia et al., 2007; Hu et al., 2009c) . The SNPs Figure 6 Protein expression of apoptosis markers induced by the INS mutant. INS1-E cells were transfected with wild-type or mutant constructs, allowing 48 h for protein expression or treated with 1 μmol/L thapsigargin (Tg) for 8 h, and total protein was extracted. Immunoblot analysis of cleaved caspase-3 and cleaved PARP protein expression. Tubulin was used as the loading control. The ratios of cleaved caspase-3/tubulin and cleaved PARP/tubulin were quantified (n = 3 independent experiments). NC, negative control (untransfected cells). Data were normalized to the values of the wildtype group and are presented as mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. WT by t-test.
were genotyped using a MassARRAY Compact Analyzer (Sequenom), and the sample call rate was >88%. The criteria for selecting individuals for WES (n = 31) was as follows: (i) positive family history of T2DM, (ii) earlier onset-age of diabetes (<50 years), (iii) lower BMI (≤26), (iv) genetic risk score in the lowest tertile (≤26), and (v) negative for autoantibodies. The genetic risk score was constructed to evaluate the T2DM susceptibility of each person, which was defined as the total number of risk alleles of 27 T2DM-predisposing and glucose metabolism-related variants previously confirmed in the Chinese population (Hu et al., 2009a (Hu et al., , b, c, 2010a Han et al., 2010; Shu et al., 2010; Cui et al., 2011; Kazakova et al., 2015) (Supplementary Figure S1) . Demographic and clinical characteristics of the 31 participants are shown in Supplementary Table S2 .
In addition, we enrolled one cross-sectional population (n = 11158) including 6523 cases, 5515 patients with T2DM, 1008 patients with impaired glucose tolerance (IGT), and 4635 controls with normal glucose tolerance (NGT), for a replication study. All patients with diabetes or IGT met the 1999 World Health Organization criteria. All control participants had normal glucose tolerance as assessed by a standard 75-g oral glucose tolerance test (OGTT). All individuals provided written informed consent, and the studies were approved by the Institutional Review Board of Shanghai Jiao Tong University Affiliated Sixth People's Hospital.
WES and genotyping
The exome capture for blood DNA from these participants was performed using Agilent SureSelect Human All Exon V4 (Agilent Technologies). The samples were then sequenced with the SOLiD Sequencing System according to the manufacturer's protocol (Applied Biosystems). Using the SOLiD platform, the mean depth was 65× in targeted regions. Variant calls were evaluated on both bulk and per-sample properties for novel and known variant counts, transition/transversion ratio, and heterozygote/homozygote ratio. The effective reads were aligned to the human reference genome (NCBI build 38). All the variants identified by WES were then validated by Sanger sequencing. The replication samples were genotyped using a MassARRAY Compact Analyzer (Sequenom).
Proinsulin construct and generation of the mutant
Human preproinsulin cDNA was cloned into the pcDNA3.1(-) vector, and enhanced green fluorescent protein was introduced between proline 72 and glycine 73 in the C-peptide. The single mutation (p.Ala2Thr, A2T) was inserted using a QuickChange Lightning Site-Directed Mutagenesis Kit (Stratagene, Agilent Technologies).
Quantification of the transient expression of mRNA and protein
INS1-E and HEK293T cells were grown in 1640 medium and DMEM supplemented with 10% fetal calf serum, respectively. They were cultured in 12-well plates and transfected in triplicates with either wild-type or mutant INS construct (2 μg/well) using Lipofectamine 2000 following the manufacturer's instructions (Invitrogen). After 24 h, samples were collected for mRNA expression analysis. Total RNA was extracted using Trizol reagent (Invitrogen), and cDNA was generated using a PrimeScript TM 1 st strand cDNA Synthesis Kit (Takara Bio). Real-time PCR was carried out with the cDNA (equivalent of 50 ng input RNA) using FastStart Universal SYBR Green Master mix (Roche Applied Science) on a 7900ht Real-Time PCR System (Applied Biosystems), with each sample analyzed in triplicates. All real-time primers were generated using ABI Primer Express 3.0 (see Supplementary Table S3 for primer sequences). The results were normalized to the expression of β-actin and were calculated according to the 2 −ΔΔCt method. For protein extraction, 48 h after transfection, the cells were washed twice with PBS and lysed in RIPA buffer containing the complete protease inhibitor cocktail P8340 (Sigma-Aldrich). The total protein was separated on 10% or 12% SDS-polyacrylamide gels (PAGE) and transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% non-fat milk for 1 h and subsequently incubated with primary antibodies against GFP, IRE1α, eIF2α, p-eIF2α, BiP, β-tubulin, cleaved-caspase-3, cleaved-PARP (Cell Signaling Technology),and p-IRE1α (Novus Biologicals) overnight at 4°C. After extensive washing with TBST buffer, the blots were incubated with horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. Then, the blots were developed with SuperSignal West Pico Chemiluminescent Substrate (Pierce) or Immunobilon Western Chemiluminescent HRP Substrate (Millipore). Each western blot was repeated for three times.
Immunocytochemistry
INS1-E rat pancreatic β cells seeded on poly-L-lysine-coated coverslips were transfected with the wild-type or mutant insulin construct (2 μg/well) using Lipofectamine 2000 and were allowed to overexpress the transfected gene for 48 h. The coverslips were washed twice with PBS, fixed in 4% paraformaldehyde for 15 min, washed again, blocked with 2% BSA for 30 min, subsequently incubated for 2 h at 37°C with a primary antibody against Calnexin (Novus Biologicals), and then washed with PBS. The cells were incubated with the appropriate secondary antibody coupled to Alexa Fluor 594 (Abcam) for 1 h at 37°C.
Finally, the cells were stained with DAPI for 2 min. The cells were imaged using a confocal microscope (Olympus Fluoview FV1000). The images were analyzed using the Olympus Fluoview Ver.2.1a Viewer software (Olympus). The IOD parameter of merged areas were measured using Image-Pro Plus software (Media Cybernetics).
Data analysis and statistics
The experiments were performed in triplicates. Data are represented as mean ± SEM. Statistical significance was determined using t-tests and chi-square tests. Differences were considered statistically significant when P < 0.05.
Supplementary material
Supplementary material is available at Journal of Molecular Cell Biology online.
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